Schedule 13G
| | | | |
CUSIP No. 82657M105 | | | | Page 3 of 5 |
ITEM 1. | (a) Name of Issuer: |
Sight Sciences, Inc. (the “Issuer”).
| (b) Address of Issuer’s Principal Executive Offices: |
4040 Campbell Ave, Suite 100, Menlo Park, California 94025
ITEM 2. | (a) Name of Person Filing: |
This statement is filed on behalf of Paul Badawi (the “Reporting Person”).
| (b) Address or Principal Business Office: |
The business address of the Reporting Person is c/o Sight Sciences, Inc., 4040 Campbell Ave, Suite 100, Menlo Park, California 94025.
| (c) Citizenship of each Reporting Person is: |
Paul Badawi is a citizen of the United States.
| (d) Title of Class of Securities: |
Common Stock, par value $0.001 per share (“Common Stock”).
82657M105
Not applicable.
(a-c)
The ownership information presented below represents beneficial ownership of Common Stock of the Issuer as of December 31, 2021, based upon 47,307,477 shares of Common Stock outstanding as of November 8, 2021 based on the Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021.